Doctors and dermatologists are warning people to avoid injecting copper peptides, after a growing trend saw the compound move from skincare products into unregulated at-home injections.
The main concern is a peptide called GHK-Cu, a copper-bound molecule made of three amino acids. It has been used in cosmetic creams for years and has some research supporting its effects on skin healing and collagen production. But experts say the injectable version is a completely different situation — and one that lacks proper human safety testing.
From skincare ingredient to self-injection trend
GHK-Cu has been studied in topical creams and serums, where it is considered relatively safe and may help with skin repair, wound healing, and signs of aging.
The problem, according to dermatologists, is that some people are now buying injectable versions online and using them at home. These products are often sold outside any regulated medical system, meaning there is no guarantee of purity, dosage, or sterility.
Doctors say this creates a serious risk because users cannot confirm what is actually inside the vial or whether it is safe to inject.
No human safety studies for injections
While topical GHK-Cu has been studied in small human trials, there are no published clinical studies showing that injecting it into the body is safe or effective.
Researchers note that most evidence beyond skincare comes from lab and animal studies. These suggest possible effects on wound healing, aging pathways, and even conditions like fibrosis, but they do not translate into proven medical treatments in humans.
Because of this gap, many clinicians are urging caution and saying the injectable form should not be used outside controlled medical research.
Reported risks include liver stress and infection
Doctors and wellness clinics have reported complications in people who injected GHK-Cu on their own.
These include:
- Injection site infections and irritation
- Possible immune reactions
- Elevated liver enzymes
- Abnormal copper levels in the blood
In some cases, it is unclear whether the peptide itself or contamination from unregulated products caused the issues. However, the risk increases significantly when substances are injected without medical supervision.
Experts say sourcing is a major problem
A key concern is the unregulated market supplying these injectable peptides.
Clinicians say many patients buy them online, self-inject, and only seek medical help after experiencing side effects. Without lab testing or medical follow-up, issues like copper overload or liver stress may go unnoticed until symptoms become serious.
Doctors stress that injections carry far higher risk than topical creams, even if the ingredient is the same.
Regulators are still reviewing the compound
The legal status of injectable GHK-Cu is still unclear.
Compounding pharmacies in the US are currently not allowed to sell it for injection, although regulators are reviewing whether that should change. An FDA advisory panel is expected to revisit the evidence in upcoming meetings.
Until then, injectable versions remain widely available through unregulated sources.
Bottom line
Experts are not calling for people to stop using copper peptides in skincare products. The warning is focused specifically on injectable GHK-Cu, where there is currently no human safety data, no approved medical use, and growing concern about unregulated products being used at home.
Doctors say the compound may still have future medical potential, but for now, injecting it is considered risky and not supported by clinical evidence.